Search results
Found 961 matches for
Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study
Coronavirus COVID-19 Main OCTRU
14 December 2023
A major clinical trial, led by the University of Nottigham and managed by the Oxford Clinical trials Research Unit (OCTRU), has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
Jonathan Cook made Professor of Clinical Trials and Medical Statistics
CSM OCTRU
7 September 2023
Jonathan Cook was successful in the 2023 University Recognition of Distinction exercise
OCTRU Pashion Study In the News
OCTRU
4 July 2023
The ongoing PASHION study being ran by the Surgical Intervention Trials Unit group was in the BBC news last week.
Antibiotic bone cement found not to reduce infection after hip replacement
Hip Main OCTRU Orthopaedics and trauma
22 June 2023
A large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.
Kadoorie research paper receives EFORT gold award
Awards Main OCTRU Trauma
19 June 2023
A paper for the PATH-2 trial has received a gold award from the European Federation of National Associations of Orthopaedics and Traumatology (EFORT).
Jonathan Cook elected as Society for Clinical Trials board member
CSM Main OCTRU Statistics and epidemiology
3 April 2023
Associate Professor Jonathan Cook has been elected to the Society for Clinical Trials (SCT) board.
New approach to nail bed injury surgery could significantly cut NHS costs
Botnar Kennedy Main OCTRU SITU
30 March 2023
According to a new Oxford study, changing clinical practice for finger injuries in children could save the NHS £720,000 per year.
OCTRU - delivering answers to important clinical questions
CSM Main OCTRU Orthopaedics and trauma RRIO SITU Statistics and epidemiology
7 March 2023
The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report